Showing results (2421-2430 of 9,335) with videos related to
Sort By:
Pageof 934
Cancer Medicine|March 22, 2019
Safety and efficacy profile of cyclin-dependent kinases 4/6 inhibitor palbociclib in cancer therapy: A meta-analysis of clinical trialsLinghong Guo, Yuanyuan Hu, Xi Chen, et al.Cancer Medicine|February 22, 2019
Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapyYaqi Wang, Jing Zhang, Menglong Zhou, et al.Cancer Medicine|February 22, 2019
Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancerTadaaki Yamada, Soichi Hirai, Yuki Katayama, et al.Cancer Medicine|February 22, 2019
Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomasSho Fujiwara, Yuriko Saiki, Kota Ishizawa, et al.Cancer Medicine|February 22, 2019
Dysregulation, functional implications, and prognostic ability of the circadian clock across cancersZekun Liu, Kai Yu, Jian Zheng, et al.Cancer Medicine|February 23, 2019
Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastomaYan Su, Lijun Wang, Xisi Wang, et al.Cancer Medicine|August 27, 2019
Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectivesEsmat Abdi, Saeid Latifi-Navid, Saber Zahri, et al.Cancer Medicine|August 29, 2019
Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancerBin Shi, Carmen Behrens, Viralkumar Vaghani, et al.Cancer Medicine|August 30, 2019
RIG-I promotes IFN/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinomaDi Jing, Weibing Zhou, Lin Shen, et al.Cancer Medicine|September 14, 2019
Current trend of worsening prognosis of prostate small cell carcinoma: A population-based studyJili Wang, Xiaoyan Liu, Yan Wang, et al.Pageof 934